Finance

Beta
Lists
SOFWF:OTCMKTS
Sofwave Medical Ltd
$16.00
0.00%
(0.00) 1D
May 28, 9:40:55 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOFWF...
Mkt. cap
1.57B
Avg. vol.
48.00
Volume
0.00
52-wk high
$16.49
52-wk low
$5.84
Shares outstanding
36.13M
No. of employees
151
Mkt. cap
1.57B
Avg. vol.
48.00
Volume
0.00
52-wk high
$16.49
52-wk low
$5.84
Shares outstanding
36.13M
No. of employees
151
News stories
From sources across the web
Profile
Sofwave Medical is an Israeli aesthetic medicine company with headquarters in California, United States. It is publicly traded, listed on the Tel Aviv Stock Exchange. Sofwave develops an ultrasound system for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles and for short term improvement in the appearance of cellulite. Wikipedia
About Sofwave Medical Ltd
CEOLouis Scafuri
Employees151
Founded2015
Headquarters-
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.99M
21.07M
28.90M
24.41M
Cost of goods sold
5.14M
5.54M
7.05M
6.11M
Cost of revenue
5.14M
5.54M
7.05M
6.11M
Research and development expenses
2.82M
3.16M
3.74M
3.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.85M
10.89M
13.96M
12.90M
Operating expense
13.68M
14.04M
17.70M
16.67M
Total operating expenses
18.81M
19.59M
24.74M
22.78M
Operating income
2.18M
1.49M
4.16M
1.63M
Other non operating income
-
-
-1.79M
-
EBT including unusual items
1.65M
1.29M
3.96M
1.46M
EBT excluding unusual items
1.65M
1.29M
3.96M
1.46M
Income tax expense
135.00K
310.00K
-136.00K
197.00K
Effective tax rate
8.17%
23.99%
-3.43%
13.51%
Other operating expenses
-
-
-
-
Net income
1.52M
982.00K
4.10M
1.26M
Net profit margin
7.23%
4.66%
14.19%
5.17%
Earnings per share
-
-
-
-
Interest and investment income
120.00K
190.00K
1.54M
316.00K
Interest expense
-647.00K
-386.00K
-
-485.00K
Net interest expenses
-527.00K
-196.00K
1.54M
-169.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
2.58M
2.00M
4.42M
2.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more